Cargando…

Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria

BACKGROUND: Studies on uptake of first dose of intermittent preventive treatment in pregnancy (IPTp) are lacking, despite it being a predictor of subsequent doses. This study aimed at assessing the determinants of uptake of first dose of IPTp among pregnant women at the State Specialist Hospital, Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Balami , Ahmed Dahiru, Md. Said, Salmiah, Mohd. Zulkefli, Nor Afiah, Bachok, Norsa’adah, Audu , Bala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687802/
https://www.ncbi.nlm.nih.gov/pubmed/33238901
http://dx.doi.org/10.1186/s12884-020-03388-8
_version_ 1783613597807542272
author Balami , Ahmed Dahiru
Md. Said, Salmiah
Mohd. Zulkefli, Nor Afiah
Bachok, Norsa’adah
Audu , Bala
author_facet Balami , Ahmed Dahiru
Md. Said, Salmiah
Mohd. Zulkefli, Nor Afiah
Bachok, Norsa’adah
Audu , Bala
author_sort Balami , Ahmed Dahiru
collection PubMed
description BACKGROUND: Studies on uptake of first dose of intermittent preventive treatment in pregnancy (IPTp) are lacking, despite it being a predictor of subsequent doses. This study aimed at assessing the determinants of uptake of first dose of IPTp among pregnant women at the State Specialist Hospital, Maiduguri. METHODS: A cross-sectional study was conducted, in which respondents were selected using a systematic random sampling method, and structured questionnaires were used to obtain information from them. Chi-squared test was used to determine factors associated with uptake of first IPTp dose, while a further multivariate logistic regression was performed to determine its predictors. RESULTS: Three hundred and eighty respondents answered the survey, whose ages ranged from 15 to 45 years, and 86.8% were multigravid. Sixty five percent of them were aware of IPTp, and 34.7% believed that IPTp could be harmful to their pregnancies. Over a half of the respondents (52.9%) believed that taking all their IPTp medicines was very good for their pregnancies, while 45.0% felt that taking their IPTp medicines was very pleasant. Only two respondents (0.5%) stated that it was very untrue that their significant others thought that they should take all their IPTp medicines. Half of the respondents said it was very easy for them to take all their IPTp medicines even if they were experiencing mild discomforts while taking them. Less than a half (42.37%) had received their first dose of IPTp. In bivariate as well as multivariate analysis, only higher level of knowledge was significantly associated with uptake of first IPTp dose. Those with better knowledge of IPTp were about twice more likely to have taken their first dose of IPTp, compared to those with lower knowledge of IPTp (AOR = 1.85; 95% CI: 1.17–2.92). CONCLUSIONS: Knowledge of IPTp as well as its uptake, were sub-optimal in this study. Since knowledge of IPTp significantly predicts uptake of the first dose of IPTp, there is the need to implement health education campaigns to raise the awareness of pregnant women and their families on the need to receive and comply with it. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-020-03388-8.
format Online
Article
Text
id pubmed-7687802
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76878022020-11-30 Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria Balami , Ahmed Dahiru Md. Said, Salmiah Mohd. Zulkefli, Nor Afiah Bachok, Norsa’adah Audu , Bala BMC Pregnancy Childbirth Research Article BACKGROUND: Studies on uptake of first dose of intermittent preventive treatment in pregnancy (IPTp) are lacking, despite it being a predictor of subsequent doses. This study aimed at assessing the determinants of uptake of first dose of IPTp among pregnant women at the State Specialist Hospital, Maiduguri. METHODS: A cross-sectional study was conducted, in which respondents were selected using a systematic random sampling method, and structured questionnaires were used to obtain information from them. Chi-squared test was used to determine factors associated with uptake of first IPTp dose, while a further multivariate logistic regression was performed to determine its predictors. RESULTS: Three hundred and eighty respondents answered the survey, whose ages ranged from 15 to 45 years, and 86.8% were multigravid. Sixty five percent of them were aware of IPTp, and 34.7% believed that IPTp could be harmful to their pregnancies. Over a half of the respondents (52.9%) believed that taking all their IPTp medicines was very good for their pregnancies, while 45.0% felt that taking their IPTp medicines was very pleasant. Only two respondents (0.5%) stated that it was very untrue that their significant others thought that they should take all their IPTp medicines. Half of the respondents said it was very easy for them to take all their IPTp medicines even if they were experiencing mild discomforts while taking them. Less than a half (42.37%) had received their first dose of IPTp. In bivariate as well as multivariate analysis, only higher level of knowledge was significantly associated with uptake of first IPTp dose. Those with better knowledge of IPTp were about twice more likely to have taken their first dose of IPTp, compared to those with lower knowledge of IPTp (AOR = 1.85; 95% CI: 1.17–2.92). CONCLUSIONS: Knowledge of IPTp as well as its uptake, were sub-optimal in this study. Since knowledge of IPTp significantly predicts uptake of the first dose of IPTp, there is the need to implement health education campaigns to raise the awareness of pregnant women and their families on the need to receive and comply with it. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12884-020-03388-8. BioMed Central 2020-11-25 /pmc/articles/PMC7687802/ /pubmed/33238901 http://dx.doi.org/10.1186/s12884-020-03388-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Balami , Ahmed Dahiru
Md. Said, Salmiah
Mohd. Zulkefli, Nor Afiah
Bachok, Norsa’adah
Audu , Bala
Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria
title Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria
title_full Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria
title_fullStr Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria
title_full_unstemmed Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria
title_short Determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health Centre in Maiduguri, Nigeria
title_sort determinants of uptake of first dose of intermittent preventive treatment among pregnant women in a secondary health centre in maiduguri, nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687802/
https://www.ncbi.nlm.nih.gov/pubmed/33238901
http://dx.doi.org/10.1186/s12884-020-03388-8
work_keys_str_mv AT balamiahmeddahiru determinantsofuptakeoffirstdoseofintermittentpreventivetreatmentamongpregnantwomeninasecondaryhealthcentreinmaidugurinigeria
AT mdsaidsalmiah determinantsofuptakeoffirstdoseofintermittentpreventivetreatmentamongpregnantwomeninasecondaryhealthcentreinmaidugurinigeria
AT mohdzulkeflinorafiah determinantsofuptakeoffirstdoseofintermittentpreventivetreatmentamongpregnantwomeninasecondaryhealthcentreinmaidugurinigeria
AT bachoknorsaadah determinantsofuptakeoffirstdoseofintermittentpreventivetreatmentamongpregnantwomeninasecondaryhealthcentreinmaidugurinigeria
AT audubala determinantsofuptakeoffirstdoseofintermittentpreventivetreatmentamongpregnantwomeninasecondaryhealthcentreinmaidugurinigeria